NEW YORK (GenomeWeb News) — Welsh research company Abcellute today said it has signed an exclusive deal with microarray service provider GeneFrontier to manufacture, market, and distribute Abcellute’s hepatocyte cell-preservation products in Japan.
 
The agreement also gives Tokyo-based GeneFrontier rights to pen sub-license deals with the technology with pharma companies.    
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.